AACR

Breast cancer researcher and oncologist Nancy Davidson discusses what we’ve learned from the first wave of epigenetic trials for breast cancer, and what challenges lie ahead before such therapies reach the clinic.

A small study finds that the tiny extracellular vesicles from patients with hepatocellular carcinoma have RNA content distinct from patients with cirrhosis only.

The former head of cancer medicine at MD Anderson Cancer Center helped change clinical practice for laryngeal cancer and helped establish chemoprevention.

Nine of the most recent retractions from AACR journals are for papers coauthored by embattled cancer researcher Bharat Aggarwal.

Experiments in mice show that mitochondria, both within the tumor and beyond, can make the difference between promoting or inhibiting cancer spread.

Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.

Certain non-chromosomal defects are strongly associated with specific childhood cancers.

Notable quotes from this year’s annual meeting of the American Association for Cancer Research

At the annual American Association for Cancer Research meeting, researchers discuss the importance of understanding the epigenetic contributors to cancer progression and treatment response.

Researchers at the annual American Association for Cancer Research meeting discuss the roles of adipose tissue and inflammation in the growth and spread of tumors.

A selection of notable quotes from the annual American Association for Cancer Research meeting

The aneuploidy expert shares what she has learned at the American Association for Cancer Research annual meeting.

The genomics pioneer shares the sessions she most looks forward to at this year’s American Association for Cancer Research annual meeting.

Hot topics in cancer research from the annual meeting of the American Association for Cancer Research

After exposure to curcumin, rat cancer cell populations undergo a daily cycle of cell death.

A National Cancer Institute model forecasts a marked increase in estrogen receptor-positive tumors among older women by 2030.

Personalized pancreatic cancer therapies based on tumor genomics may take too long to prepare to be helpful, according to a small clinical trial.

The largest and longest study of long-term, regular aspirin use finds that the drug may lead to a modestly reduced risk for some types of gastrointestinal cancers.

Emmanuel Farber, past American Association for Cancer Research president who advanced fundamental understanding of chemical carcinogenesis, has passed away at age 95.